Mexohar 150mg Capsule
By Mexohar
Rx
30 Capsule in a Bottle

Composition
Mexiletine(150mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
April, 2027

liver
When using Mexohar 150mg Capsule, it is important to be cautious if you have liver disease. Patients with liver issues may require dose adjustments when taking Mexohar 150mg Capsule. Always consult your doctor for proper guidance to ensure your safety.

kidney
Mexohar 150mg Capsule should be used carefully in patients with kidney disease, as dose adjustments may be necessary. Please consult your doctor regarding this matter.

alcohol
Consult your doctor when consuming alcohol with Mexohar 150mg Capsule.

driving
When using Mexohar 150mg Capsule, it is unclear if driving ability is affected. Avoid driving if you have any symptoms that hinder focus and reaction time.

pregnancy
Mexohar 150mg Capsule is not recommended during pregnancy as it may be unsafe. Animal studies suggest potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing it to you. Please consult your doctor before use.

breastfeeding
Mexohar 150mg Capsule is considered safe while breastfeeding. Studies show minimal risk to the baby based on limited human data.
| Habit Forming | No |
| Chemical Class | Phenol ethers |
| Therapeutic Class | - |
| Action Class | Class I Agents- anti arrhythmic |
₹2732.7
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024
